Back to search

National and Kapodistrian University of Athens

Συγκριτική αξιολόγηση ενδοϋαλοειδικού εμφυτεύματος δεξαμεθαζόνης 700mg (ozurdex) έναντι συμβατικής έγχυσης τριαμσινολόνης (volon) 4 mg σε ασθενείς με μετεγχειρητικό οίδημα της ωχράς κηλίδας

Abstract

dc:description

Aim: To evaluate the efficacy of the treatment with intravitreal triamcinolone acetonide or dexamethasone intravitreal implant in patients with postoperative cystoid macular edema (PCME).Materials and methods: Thirty eyes of 29 patients with PCME were randomized into two groups: one group initially received an injection of 4 mg triamcinolone; retreatment after 3 months was dependent on functional and anatomic outcome in a PRN regimen. The second group received a single injection of the dexamethasone intravitreal implant (Ozurdex). Patients were followed for 6 months. The main outcomes were best-corrected visual acuity (BCVA) and central millimeter retinal thickness (CMMT).Results: Mean BCVA improved significantly in both groups at 3 months (p ≤ 0.05) and 6 months (p ≤ 0.05) after treatment. There was no statistically significant difference between the two groups in visual acuity improvement at 3 months (p > 0.05) or 6 months (p > 0.05). Mean CMMT of both groups also decreased significantly after treatment at 3 and 6 months (both p ≤ 0.05) and the reduction was significantly superior in the triamcinolone group compared to ozurdex group at 1 week and 6 months (p ≤ 0.05). All cases with intraocular hypertension were managed with IOP-lowering medication and no surgery was required during the study. One patient was excluded because of endophthalmitis in the triamcinolone group.Conclusion: Intravitreal triamcinolone and dexamethasone implant are both equally effective in increasing visual acuity in patients with PCME at a 6-month follow-up. However, macular edema seems to respond more rapidly with intravitreal triamcinolone, and 3-monthly repetitive injections maintain the reduction in retinal thickness better than a single dexamethasone implant at the first 6 months of follow-up period.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2017

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Mylonas, Georgios
  • Μυλωνάς, Γεώργιος

Subjects

dc:subject × 6

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40320

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Mylonas, Georgios; Μυλωνάς, Γεώργιος. Συγκριτική αξιολόγηση ενδοϋαλοειδικού εμφυτεύματος δεξαμεθαζόνης 700mg (ozurdex) έναντι συμβατικής έγχυσης τριαμσινολόνης (volon) 4 mg σε ασθενείς με μετεγχειρητικό οίδημα της ωχράς κηλίδας. National and Kapodistrian University of Athens, 2017. http://hdl.handle.net/10442/hedi/40320